The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors

Jasper de Boer(Institute of Child Health), Hugh J.M. Brady(Imperial College London), Beat Bornhäuser(University Children's Hospital Zurich), Michael Hubank(Royal Marsden Hospital), O Solarska(University College London), Jenny Yeung(The London College), Owen Williams(Institute of Child Health), J Ellu(University College London), Ramya Ramanujachar(University College London)

Leukemia

November 12, 2010

10.1038/leu.2010.253

Cited by 42

Related Papers

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

|The Lancet Oncology|2020|351

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

|Blood|2009|347

Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

|Journal of Clinical Investigation|2010|311

<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

|Journal of Clinical Oncology|2018|304

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

|Cancer Discovery|2020|284